TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Overview Fund Activity
Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

98 hedge funds and large institutions have $900M invested in Turning Point Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 35 increasing their positions, 8 reducing their positions, and 12 closing their positions.

Holders
98
Holders Change
+28
Holders Change %
+40%
% of All Funds
2.15%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
40
Increased
35
Reduced
8
Closed
12
Calls
$425K
Puts
–
Net Calls
+$425K
Net Calls Change
+$425K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$135M
2
Wells Fargo
2
Wells Fargo
California
$20.1M
3
CAM
3
Cormorant Asset Management
Massachusetts
$133M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$45.7M
5
American Century Companies
5
American Century Companies
Missouri
$11.8M

Top Sellers

1
PC
1
Polar Capital
United Kingdom
$0
2
LCM
2
Laurion Capital Management
New York
$0
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
MWNA
5
Marshall Wace North America
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Westfield Capital Management
101
Westfield Capital Management
Massachusetts
– -$224K -5,500 Closed
AWCI
102
Alpine Woods Capital Investors
New York
– -$204K -5,010 Closed
CSS
103
Cubist Systematic Strategies
Connecticut
– -$90K -2,215 Closed
Royal Bank of Canada
104
Royal Bank of Canada
Ontario, Canada
– -$5K -112 Closed
PHK
105
Point72 Hong Kong
Hong Kong
– -$1K -29 Closed
1 2 3 4
5